PremiumCompany AnnouncementsGlucoTrack Reports Q1 2025 Financial Results and Progress GlucoTrack Gains Approval for Long-Term Clinical Study GlucoTrack receives ethical approval from St. Vincent’s HREC for CBGM study PremiumThe FlyGlucoTrack, OneTwo Analytics collaborate to study analysis on CBG Monitor Glucotrack Reports Transformative Year with Clinical Advances GlucoTrack Advances with Clinical Trials and Funding Boost PremiumCompany AnnouncementsGlucoTrack’s $3.03M Stock Offering Agreement Announced GlucoTrack prices offering of 2.6M shares of common stock at $1.15 GlucoTrack Announces Reverse Stock Split and Clinical Study Success